Related Experiment Video
Updated: Jan 20, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
An aminoglycoside antibiotic inhibits both lipid-induced and solution-phase fibrillation of α-synuclein in vitro
Anindita Mahapatra1, Sukanya Sarkar2, Subhash Chandra Biswas2
1Structural Biology and Bio-informatics Division, Indian Institute of Chemical Biology, Kolkata-700032, India. krish@iicb.res.in and Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India.
Abstract:
Parkinson's disease (PD), closely associated with the misfolding and aggregation of the neuronal protein α-synuclein (A-Syn), is a neurodegenerative disorder with no cure to date. Here, we show that the commercially available, inexpensive, aminoglycoside antibiotic kanamycin effectively inhibits both lipid-induced and solution-phase aggregation of A-Syn in vitro, pointing towards the prospective repurposing of kanamycin as a potential anti-PD drug.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Estimation of k and VD of Aminoglycosides
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Antibiotic Selection
Feedback Inhibition

